Wang Yuping, Zhu Jie, Shan Luchen, Wu Ling, Wang Cunchuan, Yang Wah
Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Department of Metabolic and Bariatric Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Front Pharmacol. 2023 Feb 8;14:1098465. doi: 10.3389/fphar.2023.1098465. eCollection 2023.
Potentially inappropriate medications (PIM) contribute to poor outcomes in older patients, making it a widespread health problem. The study explored the occurrence and risk factors of PIM in older diabetic kidney disease (DKD) patients during hospitalization and investigated whether polypharmacy was associated with it. Retrospective analysis of the patients ≥ 65 years old diagnosed with DKD from July to December 2020; the PIM was evaluated according to the American Beers Criteria (2019). Factors with statistical significance in univariate analysis were included in Logistic multivariate analysis to explore the potential risk factors related to PIM. Included 186 patients, 65.6% of patients had PIM, and 300 items were confirmed. The highest incidence of PIM was 41.7% for drugs that should be carefully used by the older, followed by 35.3% that should be avoided during hospitalization. The incidence of PIM related to diseases or symptoms, drug interactions to avoid, and drugs to avoid or reduce dose for renal insufficiency patients were 6.3%, 4.0% and 12.7%, respectively. The medications with a high incidence of PIM were diuretics (35.0%), benzodiazepines (10.7%) and peripheral ɑ1 blockers (8.7%). Compared with hospitalization, there were 26% of patients had increased PIM at discharge. Multivariate Logistic regression analysis showed that polypharmacy during hospitalization was an independent risk factor for PIM, OR = 4.471 (95% CI: 2.378, 8.406). The incidence of PIM in hospitalized older DKD patients is high; we should pay more attention to the problem of polypharmacy in these patients. Pharmacists identifying the subtypes and risk factors for PIM may facilitate risk reduction for older DKD patients.
潜在不适当用药(PIM)会导致老年患者出现不良结局,使其成为一个普遍存在的健康问题。本研究探讨了老年糖尿病肾病(DKD)患者住院期间PIM的发生情况及危险因素,并调查了多重用药是否与之相关。对2020年7月至12月诊断为DKD的65岁及以上患者进行回顾性分析;根据美国老年医学会2019版Beers标准评估PIM。单因素分析中有统计学意义的因素纳入Logistic多因素分析,以探索与PIM相关的潜在危险因素。纳入186例患者,65.6%的患者存在PIM,共确认300项。PIM发生率最高的是老年人应慎用的药物,为41.7%,其次是住院期间应避免使用的药物,为35.3%。与疾病或症状相关的PIM、应避免的药物相互作用以及肾功能不全患者应避免或减少剂量的药物的发生率分别为6.3%、4.0%和12.7%。PIM发生率较高的药物有利尿剂(35.0%)、苯二氮䓬类药物(10.7%)和外周α1受体阻滞剂(8.7%)。与住院时相比,出院时有26%的患者PIM增加。多因素Logistic回归分析显示,住院期间多重用药是PIM的独立危险因素,OR = 4.471(95%CI:2.378,8.406)。住院老年DKD患者PIM发生率较高;我们应更加关注这些患者的多重用药问题。药剂师识别PIM的亚型和危险因素可能有助于降低老年DKD患者的风险。